Crystal Parney|March 7, 2024FDA revises letter of authorization for the emergency use authorization for Paxlovid
Crystal Parney|March 6, 2024Cost of Inpatient Falls and Cost-Benefit Analysis of Implementation of an Evidence-Based Fall Prevention Program
Crystal Parney|March 6, 2024Direct to Consumer Biomarker Testing for Alzheimer Disease—Are We Ready for the Insurance Consequences?